DEBN
DEBN (Drug-Eluting Biopsy Needle) is a medical company developing a novel prostate biopsy needle for urologists which will reduce infectious complication rate. Prostate biopsy needle delivers the optimal antibiotic combination directly to the prostate, precisely at the place where potential infections start. This application method allows to use a more effective antibiotic which is not allowed for oral prophylaxis.
DEBN
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
Gdansk, Pomorskie, Poland
Country:
Poland
Website Url:
http://www.debn.eu
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Google Font API LetsEncrypt Content Delivery Network ReCAPTCHA JsDelivr AJAX Libraries API BootstrapCDN ReCAPTCHA V3
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - DEBN
Alfabeat
Alfabeat investment in Seed Round - DEBN
Official Site Inspections
http://www.debn.eu
- Host name: h24.seohost.pl
- IP address: 188.210.221.84
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw
